The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 589-596 Year: 2012
Management of severe pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 279-287 Year: 2010
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017
Social deprivation and prognosis in Scottish patients with pulmonary arterial hypertension Source: Eur Respir J, 51 (2) 1700444; 10.1183/13993003.00444-2017 Year: 2018
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018
The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012
Pulmonary hypertension: diagnosis, differential diagnosis and pitfalls Source: Eur Respir Mon 2012; 57: 17-25 Year: 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012
A critical analysis of survival in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:218-222 Year: 2012
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017
Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management Source: Eur Respir Rev 2010 19: 314-320 Year: 2010
Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals Source: Eur Respir Rev 2010 19: 272-278 Year: 2010
Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013
Predicting survival in pulmonary arterial hypertension in the UK}, Source: Eur Respir J 2012; 40: 604-611 Year: 2012
Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018 Year: 2018
A USA-based registry for pulmonary arterial hypertension: 1982 2006 Source: Eur Respir J 2007; 30: 1103-1110 Year: 2007
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014
Impact of borderline pulmonary arterial pressure on survival Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014